載入...
A heterochronic genetic change from an EGFR mutation to an ALK rearrangement in a patient with lung adenocarcinoma: a case report
An 87-year-old man with postoperative recurrent lung adenocarcinoma was treated with gefitinib. At the beginning of treatment, surgically resected archived tumor tissue revealed a deletion in exon 19 of the EGFR gene, but no ALK gene rearrangement. After gefitinib treatment for 9 months, the disease...
Na minha lista:
發表在: | J Thorac Dis |
---|---|
Main Authors: | , , , , , , , , , , |
格式: | Artigo |
語言: | Inglês |
出版: |
AME Publishing Company
2016
|
主題: | |
在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4842787/ https://ncbi.nlm.nih.gov/pubmed/27162697 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2016.03.43 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|